Metraipolis › archive › dc_323c8aeba022

Advances in gene therapy for Lafora disease: Intravenous recombinant adeno-associated virus-mediated delivery of EPM2A and EPM2B genes — Europe PMC PMID:41169091

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41169091
DOI: 10.1002/ctm2.70514
License (as archived): solo-consultazione
Archived: 2026-11-08T21:41:26.269Z
SHA-256 of the archived text: d6e51dae0806dca38dfe27f22fe0f8afb9442591afdff09549df98c849dfa072
Stable URL of this page: https://metraipolis.com/documento/dc_323c8aeba022

How to cite

Advances in gene therapy for Lafora disease: Intravenous recombinant adeno-associated virus-mediated delivery of EPM2A and EPM2B genes — Europe PMC PMID:41169091 — Europe PMC (en), https://europepmc.org/article/MED/41169091 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_323c8aeba022 (Metraipolis archive dc_323c8aeba022, sha256 d6e51dae0806dca38dfe27f22fe0f8afb9442591afdff09549df98c849dfa072)

BibTeX

@misc{dc323c8aeba022,
  title = {Advances in gene therapy for Lafora disease: Intravenous recombinant adeno-associated virus-mediated delivery of EPM2A and EPM2B genes — Europe PMC PMID:41169091},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41169091},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_323c8aeba022; sha256 d6e51dae0806dca38dfe27f22fe0f8afb9442591afdff09549df98c849dfa072},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41169091. Agents can read the archived copy with the MCP tool read_document.